Boston’s Biotech Women Take Center Stage
The last few days has seen a number of events in the Boston Biotech Cluster which have involved women executives. Here is our pick of the top 5: Annalisa Jenkins: Leads Dimension Therapeutics to an IPO...
View ArticleBoard Succession Requires Refreshing Plan
Author: Karl Simpson, Liftstream Succession planning should concern every board of directors, irrespective of whether private or public. Increasingly, public company shareholders and representative...
View ArticleWomen Executives: Stepping Up to the C-suite and Board (Event Schedule)
Event Date: Thursday, December 3, 2015 from 4:00 PM to 7:30 PM (EST) Event Location: Biogen, Bio-9 Building, 300 Binney Street Cambridge, MA 02142 – View Map Register FREE for the event here Download...
View ArticleHans Schikan new Chair at InteRNA and Asceneuron
Hans Schikan is former Chief Executive Officer of Prosensa, a biopharmaceutical company focusing on novel RNA modulating treatments for rare diseases like Duchenne muscular dystrophy. Prosensa was...
View ArticleIntellia Appoints Caroline Dorsa to Board of Directors
Intellia Therapeutics, a genome editing company based in Cambridge, Massachusetts, has named Caroline Dorsa to its Board of Directors. Her appointment will help advance the company’s mission of...
View ArticleAlnylam Elects Chairman and Board Member
Alnylam Pharmaceuticals, a biopharmaceutical company headquartered in Cambridge, Mass, has named Michael Bonney as Chairman to replace John Clarke who stepped down after 13 years of service. Clarke...
View ArticleRodin Adds Samantha Singer to Board of Directors
Rodin Therapeutics, a biotechnology company developing therapeutics for neurological disorders based in Cambridge, Mass, has appointed Samantha Singer as an independent member of the company’s board of...
View ArticleIdera Pharmaceuticals Elects Maxine Gowen to Board of Directors
Idera Pharmaceuticals, a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and rare diseases, has appointed Maxine Gowen to its board...
View ArticleScott Morrison Nets Two Board Appointments
Scott Morrison, a retired Ernst & Young Partner, was appointed to the board of directors at Audentes Therapeutics and Global Blood Therapeutics. Audentes Therapeutics is a San Francisco-based...
View ArticlePsiOxus Therapeutics Elects Paolo Paoletti as Chairman of the Board
PsiOxus Therapeutics, an immuno-oncology company in Oxford, England, has appointed Paolo Paoletti to Chairman of its Board to replace Michael Moore. Moore will remain on the Board as Deputy Chairman....
View ArticleEditas Medicine Appoints John D. Mendlein to Board of Directors
Editas Medicine, a genome editing company based in Cambridge, Mass, has appointed John D. Mendlein to its board of directors. Mendlein has served as CEO of aTyr Pharma since 2011, as well as executive...
View ArticleNorthwest Biotherapeutics Strengthens Board Capability
Northwest Biotherapeutics (NW Bio), a biotechnology company developing personalised immunotherapy products based in Bethesda, Maryland, has appointed Susan Bayh and Cofer Black as independent...
View ArticleOxford Pharmascience Group appoints Director to Board
Oxford Pharmascience, a London-based company which redevelops medicines, has appointed Anand Sharma as a non-executive director. Sharma is currently a director of Growth Angle, a marketing and...
View ArticleZavante Therapeutics Closes Series A Financing And Brings Directors To Board
Zavante Therapeutics, a late clinical-stage biopharmaceutical company based in San Diego, California, has closed a $45 million Series A financing, consisting of $35 million from new investors and $10...
View ArticleScope for Board Improvement Among San Diego Biotechs
Biotech clusters are big business. They attract investment, spur innovation and create economic prosperity for the local economy, let alone the bragging rights that come from market superiority. In the...
View ArticleShire adds to board with appointment of Ian Clark
Shire plc has joined Agios Pharmaceuticals in announcing the appointment of Ian Clark to the Board of Directors. Mr. Clark served as Chief Executive Officer and Director of Genentech Inc (part of the...
View ArticleBoard Directors with Frequency
Frequency Therapeutics, based in Cambridge, MA, is a company spearheading the movement to restore hearing by harnessing the regenerative potential of progenitor cells in the body, today announced its...
View ArticleLeaders on the Front Line
In striving for your goals, you’re occasionally given a cause to reflect on where you’ve come from. For Liftstream, that occasion arrived in September of this year when being nominated by industry...
View ArticleWhy don’t you simply ask?
Opportunities for women to move into leadership positions are not materialising as frequently as they are for men: C-suite women are much less likely to be contacted for a potential board position...
View Article
